As part of the fiscal cliff legislation enacted prior to the end of 2012, $10.5 billion in Medicare overpayments to hospitals will be recovered over the next few years.
The U.S. Department of Health and Human Services has approved $1.5 billion in new Exchange Establishment Grants to ensure states have the required resources to build marketplaces that meet the needs of residents.
The U.S. Department of Health andHuman Services has relaunched its website to attract the 43 million uninsuredAmericans needed to make the healthcare law work when open enrollment in state and federal healthcare exchanges begins in October 2013.
Under the Affordable Care Act’s “10essential health benefits,” individual and small group health plans sold under state-based health insurance exchanges and outside them on the private market will be required to cover pediatric dental services beginning in 2014.
The U.S. Food and Drug Administration has approved Fluarix Quadrivalent to immunize children ages 3 and older and adults against flu virus subtypes A and B.
Danish investigators conducted a trial of adult patients to test whether subcutaneous immunoglobulin therapy is a viable alternative to intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyradiculoneuropathy.
Octapharma USA has started an initiative to make octagam (immune globulin intravenous [human] 5%), a therapy for primary immune deficiency, widely available to covered entities in the 340B Drug Pricing Program.
According to two recent studies, the flu vaccine may cut the risk of a heart attack or stroke by up to 50 percent.
U.S. and Italian investigators performed a meta-analysis of randomized controlled trials to quantify the effect of albumin administration on renal impairment and mortality in patients with spontaneous bacterial peritonitis.
A new global study of flu pandemics shows that a large number of elderly individuals are often immune to influenza because their bodies had been infected with a similar virus in the past.
CSL Biotherapies, a subsidiary of CSL Limited, has won a supply contract for pre-pandemic and pandemic vaccine antigens and related services to theU.S. national stockpile from the U.S.Department of Health and Human Services.
